Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
Amir-Houshang OmidvariIris Lansdorp-VogelaarHarry de KoningReinier G S MeesterPublished in: PloS one (2021)
Assumptions on future costs, utility and mortality from other causes of morbidity substantially impact cost-effectiveness outcomes of cancer screening. More empiric evidence and consensus are needed to guide assumptions in future analyses.